Satiety clinical trials

Explore recruiting satiety clinical trials.

Recruiting satiety studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Satiety trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of proton pump inhibitors on the structural integrity of endoscopic sleeve gastroplasty: a single-centre open-label, randomized, controlled pilot clinical trial

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Double-blind, randomised, placebo-controlled, dose-finding phase IIb trial to evaluate the efficacy, safety, and tolerability of a 12-week-treatment with Naronapride in adult participants with at least moderate idiopathic or diabetic gastroparesis

Italy, Austria, Belgium, Netherlands, Germany, Poland +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-Blinded, Placebo-Controlled Exploratory Study to Investigate the Efficacy and Safety of Flexible dosing of Oral Lidocaine (ORE-001) to Reduce Abdominal Discomfort and Prevent Early Satiety in Anorexia Nervosa Patients

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

The impact of pramlintide on top of semaglutide in obese people with prediabetes

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Octreotide treatment to improve nutritional recovery after surgery for patients with esophageal or gastric cancer, a prospective randomized open label phase II study - OTIS

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living with Obesity Who Do Not Have Diabetes

Poland, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Satiety trials by city

Satiety in Toronto Satiety in Vancouver Satiety in Montreal Satiety in Calgary Satiety in Edmonton Satiety in Ottawa Satiety in Winnipeg Satiety in Quebec City Satiety in Hamilton Satiety in Kitchener Satiety in London Satiety in Halifax Satiety in New York Satiety in Los Angeles Satiety in Chicago Satiety in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease